Abstract
Background: Tumor-infiltrating B lymphocytes (TIB) are often observed in lung cancer. The role of TIB in tumor growth has not been well investigated. Materials and Methods: Forty-four surgically-resected human lung cancer tissues were xenotransplanted into SCID mice. Their blood was collected and the volume of the transplanted tumors was measured regularly. The correlations between the IgG titer in the sera and the growth of the transplanted tumors according to the clinicopathological variables were examined. Results: Human IgG production from TIB was observed in the all xenotransplanted mice. Twenty-seven out of the 44 tumors regressed gradually. The average serum human IgG level of the tumor regressors (n=10) was significantly higher than that of the progressors (n=9) in squamous cell carcinoma (p=0.02), while there was no significant difference in the other histological groups. Conclusion: IgG produced by TIB might play a crucial role in preventing tumor growth in squamous cell carcinoma.
Footnotes
-
Abbreviations: SCID mouse, severe combined immunodeficiency mouse; TIL, tumor-infiltrating lymphocytes; TIB, tumor-infiltrating B lymphocytes; SEREX, serological analysis of recombinant cDNA expression libraries of human tumors.
- Received February 28, 2006.
- Accepted April 4, 2006.
- Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved